Dr. Kathryn Ann Gold, MD

  • San Diego, CA
  • Medical oncologist
NPI1306909791PAC ID3476615485
Medicare services, 2024
642
Medicare patients, 2024
104
Part D claims, 2024
331
Publications
62
Clinical trials
2
Practice address
200 W Arbor Dr, San Diego, CA 92103
Practice phone
Call (619) 543-6222
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UCSD Hillcrest Medical Center

San Diego, California

See all 4 affiliations

Find Dr. Gold's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Kathryn Ann Gold is a medical oncologist in San Diego, California

Dr. Gold practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Gold's NPI, 1306909791, was assigned on December 18, 2006. Dr. Gold graduated from WashU Medicine in 2005. Dr. Gold holds California license 0139391.

NPI and contact details
Medicare PAC ID
3476615485
NPI enumeration date
December 18, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(619) 543-6222
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Kathryn Ann Gold practices at UCSD Hillcrest Medical Center in San Diego, California

Dr. Gold's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

  • UCSD Hillcrest Medical Center
    200 W Arbor Dr, San Diego, CA 92103 · San Diego CountyPhone(619) 543-6222

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Kathryn Ann Gold is affiliated with 3 sites of care and 1 medical group

Dr. Gold's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Gold is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Gold to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Gold

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Kathryn Ann Gold's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gold practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UCSD Hillcrest Medical CenterAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Gold practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Kathryn Ann Gold is one of 415 medical oncologists in California

Medical oncology is Dr. Gold's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Gold is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Gold's licenses on file in 3 states: California, Texas and Pennsylvania.

Specialties and state licenses

  • Medical oncology, CaliforniaPrimaryLicense 0139391 · 2015 to 2027 · taxonomy 207RX0202X
  • Hematology and oncology, TexasLicense N0050 · 2008 to 2024 · taxonomy 207RH0003X
  • Internal medicine, PennsylvaniaLicense MT185750 · 2005 to 2008 · taxonomy 207R00000X

Clinical focus

Dmand AI lists lung cancer among the conditions Dr. Gold treats.

Medical oncologists near Dr. Gold

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Kathryn Ann Gold billed Medicare for 642 services in 2024

CMS data shows 642 Medicare services from Dr. Gold across 4 procedure codes in 2024, for 104 Medicare patients. Medicare paid $44,703 for them.

Medicare services, 2024642
Medicare patients104
Paid by Medicare$44,703
Procedure codes4

Dr. Gold's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5332024: 38528%
Other services
2023: 02024: 257

Where Dr. Gold's Medicare services took place, 2024

  • In an office8113%
  • In a facility56187%

Dr. Gold compared with the California median for medical oncologists, 2024

  • Dr. Gold
  • California median
Medicare services
642vs 49629% above
Medicare patients
104vs 15432% below
Part D claims
210vs 14446% above

Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.

Dr. Gold's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Gold

Need commercial claims for Dr. Gold?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gold and other medical oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Kathryn Ann Gold treated 104 Medicare patients in 2024, average age 74

CMS counts 104 Medicare patients who saw Dr. Gold in 2024. The largest group is 65 to 74, with 51 patients. 71% of them have cancer, and 66% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gold's median patient age at 69, with 44% women.

Medicare patients, 2024104
Average age74
Average risk score2.45
Also on Medicaid27%

Dr. Gold's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Gold's Medicare patients by sex, 2024

  • Women4947%
  • Men5553%

Chronic conditions among Dr. Gold's Medicare patients, 2024

  1. Cancer71%
  2. High cholesterol66%
  3. High blood pressure65%
  4. Arthritis44%
  5. COPD33%
  6. Mood disorders31%
  7. Depression29%
  8. Ischemic heart disease29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Gold's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Kathryn Ann Gold wrote 331 Medicare Part D claims in 2024

In 2024, Dr. Gold wrote 331 Medicare Part D claims for 49 patients. 60% of them were for generic drugs. CMS names the drug for 210 of them, across 10 drugs with 11 or more claims each, at $1,534,009 in total drug cost. In 2023, CMS named 307 claims across 10 drugs.

Part D claims, 2024331
Drugs named by CMS10
Total drug cost$1.5M
Part D patients49

Dr. Gold's Part D claims by kind of drug, 2024

  • Generic198 claims60%
  • Brand-name and other133 claims40%

Dr. Gold's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Gold's Part D claims, 2024

  • Antibiotics4%12 of 331 claims
  • Antipsychotics, patients 65 and over4%13 of 331 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3072024: 21032%

Drugs named by CMS: 10 in 2024, 10 in 2023.

See all prescribing by Dr. Gold

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Kathryn Ann Gold scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gold for performance year 2024, reported as part of a group. Dr. Gold accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gold as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Gold's MIPS scores, performance year 2024

  • 91of 100Final score
  • 84.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Gold by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Kathryn Ann Gold has 62 publications on record

Dmand AI links 62 papers to Dr. Gold, published from 2011 to 2024. 2015 was the busiest year, with 7. The most frequent topics are Lung Neoplasms, Antineoplastic Agents and Carcinoma, Non-Small-Cell Lung. Dr. Gold has published most often in Clin Cancer Res. Dr. Gold's most frequent co-authors are Edward S. Kim, MD, William Nassib William, MD and John V. Heymach, MD.

Papers62
Years published2011 to 2024

Dr. Gold's papers by year, 2015 to 2024

Topics Dr. Gold writes about most

  • Lung Neoplasms
  • Antineoplastic Agents
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Squamous Cell
  • Squamous Cell Carcinoma of Head and Neck
  • Biomarkers, Tumor
  • ErbB Receptors
  • Head and Neck Neoplasms

Dr. Gold's most frequent co-authors

Recent publications by Dr. Gold

See all 62 publications and co-authors

See who Dr. Gold researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gold works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Kathryn Ann Gold has worked on 2 clinical trials

Dmand AI links Dr. Gold to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Skin Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

Clinical trials with Dr. Gold by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 2: 1 trial
  3. NonePhase 3: no trials
  4. NonePhase 4: no trials

Conditions in Dr. Gold's trials

  • Skin Neoplasms
  • Squamous Cell Carcinoma of Head and Neck
  • Carcinoma, Squamous Cell
  • Skin Diseases

Investigators on the most trials with Dr. Gold

Recent clinical trials with Dr. Gold

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Kathryn Ann Gold received $89,062 in industry payments from 2016 to 2025

CMS Open Payments shows 101 general payments to Dr. Gold from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 80% of the total. AstraZeneca Pharmaceuticals LP paid the most, $33,981.

General payments to Dr. Gold by program year, 2016 to 2025

General payments to Dr. Gold by kind, 2016 to 2025

$89.1Kin total
  • Consulting fees$71,60880%
  • Travel and lodging$8,0129%
  • Speaker and faculty fees$7,0508%
  • Food and beverage$2,0362%
  • Other$3550%

Companies that paid Dr. Gold the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Gold

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Kathryn Ann Gold graduated from WashU Medicine

Dr. Gold graduated from WashU Medicine in 2005.

  1. Medical schoolWashU Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Kathryn Ann Gold accepts plans from 14 insurance carriers

Dr. Gold is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.

Plan types Dr. Gold accepts, by number of carriers

  1. Medicare10
  2. PPO9
  3. HMO8
  4. EPO4
  5. POS4

Source: Dmand AI Insurance Network Data

Sources for Dr. Kathryn Ann Gold's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Kathryn Ann Gold

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Kathryn Ann Gold's NPI number?

Dr. Kathryn Ann Gold's NPI number is 1306909791. It was assigned on December 18, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Kathryn Ann Gold?

Dr. Kathryn Ann Gold is a medical oncologist in San Diego, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Kathryn Ann Gold practice?

Dr. Gold practices at 200 W Arbor Dr, San Diego, CA 92103. Dr. Gold's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dmand AI also links Dr. Gold to 1 group practice or clinic.

What is Dr. Kathryn Ann Gold's office phone number?

The practice phone on file for Dr. Gold is (619) 543-6222.

What is Dr. Kathryn Ann Gold's medical license number?

Dr. Gold holds California license 0139391, one of the licenses on file in 3 states.

Which states has Dr. Kathryn Ann Gold been licensed in?

Dmand AI has state licenses on file for Dr. Gold in California (2015 to 2027), Texas (2008 to 2024) and Pennsylvania (2005 to 2008).

Which hospitals is Dr. Kathryn Ann Gold affiliated with?

Dr. Gold is affiliated with Hillcrest Medical Center.

What medical group is Dr. Kathryn Ann Gold part of?

Dr. Gold is linked to UC San Diego Health.

Does Dr. Kathryn Ann Gold accept Medicare?

Yes. CMS data shows Dr. Gold billed Medicare for 642 services in 2024, and Dr. Gold accepts Medicare assignment.

Does Dr. Kathryn Ann Gold offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Gold as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Kathryn Ann Gold's MIPS score?

Dr. Gold's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

How many Medicare patients does Dr. Kathryn Ann Gold see?

CMS counts 104 Medicare patients who saw Dr. Gold in 2024, with an average age of 74.

Is Dr. Kathryn Ann Gold board certified?

Yes. Dr. Gold is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Kathryn Ann Gold bill to Medicare?

In 2024, Dr. Gold's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

Where did Dr. Kathryn Ann Gold go to medical school?

Dr. Gold graduated from WashU Medicine in 2005.

What drugs does Dr. Kathryn Ann Gold prescribe most?

In 2024 Medicare Part D data, Dr. Gold's most prescribed drugs by claims were Tagrisso, Levothyroxine Sodium and Lorbrena.

Has Dr. Kathryn Ann Gold received payments from drug or device companies?

CMS Open Payments shows $89,062 in general payments to Dr. Gold from 14 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Kathryn Ann Gold been practicing?

Dr. Gold graduated from medical school in 2005, 21 years ago.

Does Dr. Kathryn Ann Gold do research?

Dmand AI links 62 publications to Dr. Gold, published from 2011 to 2024. Dr. Gold has worked on 2 clinical trials.

Who does Dr. Kathryn Ann Gold publish with?

Dr. Gold's most frequent co-authors are Edward S. Kim, MD (8 shared papers), William Nassib William, MD (7 shared papers) and John V. Heymach, MD (5 shared papers).

What insurance does Dr. Kathryn Ann Gold accept?

Dr. Gold is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)